Ironwood Pharmaceuticals Income from Continuing Operations (Quarterly)
View 4,000+ financial data types
Ironwood Pharmaceuticals Income from Continuing Operations (Quarterly) Chart
Ironwood Pharmaceuticals Historical Income from Continuing Operations (Quarterly) DataPro Export Data Date Range:
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
About Income from Continuing Operations
Income Statement line item that does not account extraordinary items and discontinued operations. This metric is frequently used because it excludes items that are unlikely to happen the next reporting period.
For instance, if MSFT had five billion in Income, and 2 billion in an exceptional item charge, its income would be a reported 3 billion. Because the exceptional charge is unlikely to be repeated in the next quarter, some investors prefer to see what MSFT's income was BEFORE charges.
View Income from Continuing Operations (Quarterly) for IRWD.
Start Your YCharts Pro Gold Membership.
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
YCharts Pro Gold is only $99 / month.Get Started Now
Already a YCharts Pro Gold Member? Sign in here.
IRWD Income from Continuing Operations (Quarterly) Benchmarks
|Synergy Pharmaceuticals||Go Pro|
|Forest Laboratories||Go Pro|
|Sucampo Pharmaceuticals||Go Pro|
IRWD Income from Continuing Operations (Quarterly) Range, Past 5 Years
|Minimum||Go Pro||Mar 2013|
|Maximum||Go Pro||Sep 2012|
Business Wire 02/24 16:00 ET
Street Insider 02/19 12:12 ET
GlobeNewswire 02/18 08:30 ET
The Street 02/14 07:10 ET
Yahoo 02/13 13:04 ET
Business Wire 02/13 08:00 ET
The Street 02/13 01:00 ET
Business Wire 02/12 08:00 ET